United States
Germany
Japan
United Kingdom
China
CD63 mouse monoclonal antibody, clone OTI2G6 (formerly 2G6)
| Applications | FC, IHC, WB |
| Reactivities | Human |
Antibodies
CD63 mouse monoclonal antibody, clone OTI1D12 (formerly 1D12)
| Applications | FC, IHC |
| Reactivities | Human |
CD63 mouse monoclonal antibody, clone OTI2G6 (formerly 2G6)
| Applications | FC, IHC, WB |
| Reactivities | Human |
CD63 mouse monoclonal antibody, clone OTI7F1 (formerly 7F1)
| Applications | IHC, WB |
| Reactivities | Human |
CD63 mouse monoclonal antibody, clone OTI1E4 (formerly 1E4)
| Applications | FC |
| Reactivities | Human |
CD63 mouse monoclonal antibody, clone OTI3E5 (formerly 3E5)
| Applications | FC |
| Reactivities | Human |
CD63 mouse monoclonal antibody, clone OTI2A2C12 (formerly 2A2C12)
| Applications | FC |
| Reactivities | Human |
CD63 mouse monoclonal antibody, clone OTI1D12 (formerly 1D12)
| Applications | FC, IHC |
| Reactivities | Human |
CD63 mouse monoclonal antibody, clone OTI7F1 (formerly 7F1)
| Applications | IHC, WB |
| Reactivities | Human |
CD63 mouse monoclonal antibody, clone OTI2A2C12 (formerly 2A2C12)
| Applications | FC |
| Reactivities | Human |
CD63 mouse monoclonal antibody, clone OTI1E4 (formerly 1E4)
| Applications | FC |
| Reactivities | Human |
CD63 mouse monoclonal antibody, clone OTI3E5 (formerly 3E5)
| Applications | FC |
| Reactivities | Human |
